Middle East Laparoscopic Gynecological Procedures Market (2025 - 2033)

Market Size & Trends

The Middle East laparoscopic gynecological procedures marketsize was estimated at USD 97.1 million in 2024 and is projected to reach USD 145.5 million in 2033, growing at a CAGR of 4.7% from 2025 to 2033. The market's growth is attributed to factors such as the increasing prevalence of gynecological conditions, such as endometriosis, uterine fibroids, and ectopic pregnancies. The growing awareness among patients and healthcare professionals regarding the benefits of laparoscopic procedures is further fueling market growth.

This awareness is enhanced by educational campaigns, advancements in medical technology, and the increasing availability of skilled surgeons trained in laparoscopic techniques.

Also, the rising healthcare spending in several Middle Eastern countries, along with the governments’ efforts to improve the healthcare infrastructure, constitute a good atmosphere for advanced surgeries to be taken. The development of private healthcare facilities, in which the most recent technology is usually used, is also a factor that has a positive effect on the market growth.

Most Middle Eastern countries have stronger healthcare budgets, more widespread insurance or government reimbursement, better access to advanced surgical equipment, and more stable investment in surgeon training. According to a statement by the International Federation of Gynecology (FIGO), globally, low-income and lower-middle-income countries report that 0.2%-14.7% of all gynecologic surgeries are minimally invasive.

The UAE's significant drive toward cutting-edge, minimally invasive gynecological care has been fueling market growth. In 2022, Sheikh Shakhbout Medical City (SSMC), a joint venture between SEHA (Abu Dhabi Health Services Company) and Mayo Clinic, expanded its robotic surgery offerings to include gynecology. This expansion marks a major investment in surgical technology and building institutional capacity for complex laparoscopic and robotic procedures.

Also in May 2023, Burjeel Holdings in Abu Dhabi opened the Advanced Gynecology Institute (AGI) at its flagship hospital, Burjeel Medical City. The AGI was set up in partnership with IFEM Endo (Franco-European Multidisciplinary Institute of Endometriosis Academy) and includes specialized clinics for gynecological oncology, endometriosis care, and complex gynecology. The institute features state-of-the-art surgical suites that can handle laparoscopic and robotic surgeries, to make minimally invasive procedures like those for fibroids, endometriosis, and benign ovarian masses more accessible.

Adoption of Gynecological Procedures in the Middle East

Source: WHO Country Surgical Profiles, GVR Analysis

Market Concentration & Characteristics

The Middle East’s laparoscopic gynecological procedures industry is driven by advanced surgical tech, skilled specialists, and supportive regulations. Countries such as the UAE, Saudi Arabia, and Qatar serve as regional hubs, attracting patients across the Gulf via growing medical tourism. Hospitals in Dubai, Abu Dhabi, and Riyadh promote laparoscopic hysterectomy, myomectomy, and endometriosis surgery as safer, quicker options, especially in private and tertiary care hospitals investing in robotic and imaging technology. Regulatory bodies focus on surgical standards, boosting patient trust and safety benchmarks and competition centers on expertise, multidisciplinary care, and patient recovery. The market favors excellence centers with tech, international collaborations, and continuous training to enhance women’s health services.

The MEA market for laparoscopic gynecological procedures is experiencing a steady increase in innovation, mainly driven by the adoption of advanced surgical platforms and improvements in visualization and energy-based devices. Wealthier countries in the Gulf, such as the UAE and Saudi Arabia, are at the forefront with investments in robotic-assisted laparoscopy, high-definition 3D imaging systems, and minimally invasive tools designed to reduce recovery times and enhance surgical precision. Innovations are also appearing in training, with simulation-based learning and international collaborations allowing surgeons to develop their laparoscopic skills more efficiently.

Mergers and acquisitions in the Middle Eastern laparoscopic sector are more apparent among healthcare providers and hospital groups than in device manufacturing. Private hospital chains such as NMC Health and Mediclinic in the UAE and regional players in Saudi Arabia pursue acquisitions and partnerships to expand surgical services, including gynecology. On the device side, companies like Johnson & Johnson (Ethicon) and Medtronic strengthen their distribution networks by acquiring local distributors or regional partnerships. While M&A among device makers is limited, healthcare provider consolidation boosts access to laparoscopic tech by creating economies of scale for procurement and training.

Regulatory frameworks are crucial in shaping the adoption of laparoscopic gynecological procedures across the Middle East. In countries such as the UAE, Saudi Arabia, and Qatar, health authorities have implemented strict guidelines for licensing surgeons, accrediting hospitals, and approving medical devices in minimally invasive gynecology. For example, the UAE Ministry of Health and Prevention (MOHAP) and the Dubai Health Authority (DHA) require surgeons to complete specialized training and certification before performing advanced laparoscopic and robotic surgeries. Similarly, the Saudi Food and Drug Authority (SFDA) carefully oversees the import, testing, and approval of laparoscopic instruments and robotic platforms to ensure only high-quality, clinically validated technologies are used in hospitals.

Although laparoscopic gynecological surgery is gaining strong traction in the Middle East, it faces competition from traditional and emerging alternatives. In many public hospitals, especially in countries such as Egypt, Jordan, and Lebanon, open surgery (laparotomy) remains common due to cost considerations, uneven availability of advanced equipment, and disparities in surgeon training. At the other end of the spectrum, in high-income Gulf states such as the UAE, Saudi Arabia, and Qatar, robotic-assisted gynecological surgery is emerging as a premium alternative to conventional laparoscopy, particularly for complex hysterectomies, deep endometriosis cases, and gynecological oncology.

Government-led initiatives and private sector investment are driving the expansion of laparoscopic gynecology in the region. In the Gulf states, hospitals are quickly increasing their capacity and promoting advanced gynecological laparoscopy services to attract patients across the Middle East and beyond. Institutions like Abu Dhabi’s Burjeel Medical City and Riyadh’s King Faisal Specialist Hospital are showcasing themselves as regional centers of excellence.

Procedure Insights

The laparoscopic hysterectomy segment held the largest revenue share in 2024, due to the increasing clinical preference for minimally invasive alternatives to traditional open surgeries. Surgeons and healthcare systems prioritize laparoscopic techniques due to reduced patient recovery time, minimized postoperative pain, and lower complication risks. Among all gynecological laparoscopic procedures, hysterectomy has consistently maintained a strong foothold due to its applicability across several indications, such as uterine fibroids, endometriosis, adenomyosis, and early-stage cancers. AI is also being integrated into surgical training in the region. Simulation labs in institutions like Sheikh Shakhbout Medical City (UAE) and King Saud University Medical City (Saudi Arabia) have introduced AI-powered laparoscopic simulators that assess surgeon performance, provide real-time feedback, and help accelerate the learning curve for complex procedures such as hysterectomy or myomectomy.

The laparoscopic myomectomy segment is expected to experience significant growth driven by increasing preference of patients and providers toward minimally invasive treatments for uterine fibroids. The procedure’s ability to offer reduced postoperative pain, faster recovery times, minimal scarring, and lower hospital stays makes it a preferred choice for patients and surgeons. The rising prevalence of uterine fibroids further increases the demand for effective solutions, which is driving the demand for laparoscopic myomectomy.

End-use Insights

The hospitals segment held the largest revenue share in 2024, reflecting the rising demand due to the transition from traditional surgeries to laparoscopic procedures and access to advanced laparoscopic infrastructure, trained personnel, and postoperative care capabilities. Hospitals are equipped to handle complex gynecological laparoscopic cases such as severe endometriosis excision, hysterectomies for large uteri, and oncology-related staging procedures. Thus, referring gynecologists increasingly direct patients to hospitals for comprehensive diagnostic and therapeutic laparoscopic interventions. For instance, in 2023, Burjeel Medical City in the UAE launched the Advanced Gynecology Institute (AGI) in collaboration with IFEM Endo. The institute specializes in complex gynecology care, offering minimally invasive, laparoscopic, and robotic surgeries for conditions such as fibroids, benign ovarian masses, endometriosis, and gynecological cancers.

The ambulatory surgery centers (ASCs) segment is expected to experience significant growth, benefiting from the increasing shift of healthcare delivery from inpatient to outpatient settings. Laparoscopic gynecology procedures such as hysterectomy, myomectomy, and endometriosis excision are increasingly performed in ASCs because of their minimally invasive nature, shorter recovery times, and reduced postoperative complication rates. ASCs typically operate with lower overheads than hospitals, making them a cost-effective choice for providers and payers. This enables ASCs to attract higher volumes of patients while maintaining profitability. Moreover, as value-based care influences providers, gynecologic surgeons are increasingly aligning with ASC settings.

Country Insights

The laparoscopic gynecological procedures market in Qatar has taken significant steps to incorporate minimally invasive gynecological surgery into its healthcare system. For example, Al Wakra Hospital recently earned global accreditation as a Center of Excellence in Minimally Invasive Gynecology from the Surgical Review Corporation, emphasizing its high standards in clinical protocols, staff expertise, infrastructure, and patient safety. Additionally, Al-Ahli Hospital's Obstetrics and Gynecology Department has experienced an increase in laparoscopic procedures, not only for elective conditions like ovarian cysts and fibroids but also for emergency cases such as ectopic pregnancies and ovarian torsion. The hospital emphasizes safe, same-day discharge when possible, as well as smaller incisions, less pain, and quicker recovery times associated with laparoscopy compared to traditional open surgery.

The laparoscopic gynecological procedures market in Oman is also well-established at major hospitals, especially for non-cancerous gynecological conditions and reproductive health. The Royal Hospital in Muscat provides advanced endoscopic and laparoscopic procedures, including laparoscopic hysterectomy, myomectomy, endometriosis treatment, and complete staging surgeries for gynecologic cancers (including pelvic and para-aortic lymph node removal), when necessary. Likewise, Starcare Hospital in Barka offers a wide range of laparoscopic gynecologic surgeries: single-port total hysterectomy, laparoscopically assisted vaginal hysterectomy, fallopian tube recanalization, fibroid and ovarian surgeries, diagnostic procedures, and operative hysteroscopy.

The laparoscopic gynecological procedures market in Saudi Arabia is witnessing significant growth, driven by the government's strategic initiatives to modernize healthcare infrastructure, as part of Vision 2030, which has led to substantial investments in advanced surgical technologies. This modernization has facilitated the adoption of minimally invasive techniques, such as laparoscopy, which offer benefits like reduced recovery times and minimized surgical risks. Moreover, the high prevalence of chronic conditions, including obesity and gastrointestinal disorders, coupled with gynecological conditions such as endometriosis and uterine fibroids, necessitates surgical interventions, further fueling the demand for laparoscopic procedures. According to the Saudi Arabia Council of Health Insurance, the prevalence of endometriosis in the country is estimated to be around 10% among women of all reproductive ages. The integration of cutting-edge technologies, such as robotic-assisted laparoscopic systems and high-definition imaging tools, has enhanced the precision and efficiency of these procedures, aligning with the country's efforts to become a leading healthcare hub in the Middle East.

The UAE laparoscopic gynecological procedures market growth can be attributed to the increasing adoption of minimally invasive surgical techniques among gynecologists and patients, owing to the several benefits of laparoscopic procedures, including reduced recovery time, less postoperative pain, and improved cosmetic outcomes. Additionally, the UAE's healthcare sector has witnessed significant advancements in recent years, focusing on improving the quality of care and patient outcomes. The adoption of laparoscopic gynecological procedures is also substantially increasing, with many healthcare providers incorporating cutting-edge technology into their services. For instance, in October 2024, Burjeel Holdings launched the Trust Fertility Clinic, which is the UAE’s largest fertility center offering advanced reproductive solutions with personalized, evidence-based care. The clinic integrates comprehensive fertility treatments, including egg retrieval, embryo transfer, IUI, IVF, and laparoscopic surgery for fertility-related conditions, leveraging AI-driven embryo selection technology for optimal outcomes.

The laparoscopic gynecological procedures market in Kuwait is driven by evolving patient preferences, technological advancements, and shifts in healthcare infrastructure. The increasing awareness among Kuwaiti women regarding the benefits of minimally invasive procedures, coupled with the government's focus on improving healthcare standards and infrastructure, is fueling the market growth. Moreover, the private sector's investment in advanced medical technologies to offer comprehensive laparoscopic gynecology procedures also contributes to market growth. Moreover, the increasing emphasis on patient safety and the reduction of complications associated with traditional open surgeries contribute to the rising adoption of laparoscopy.

Key Middle East Laparoscopic Gynecological Procedures Company Insights

Leading players such as Medtronic plc, Johnson & Johnson, and Intuitive Surgical are propelling the growth of the laparoscopic gynecological procedures industry in the Middle East. These companies leverage advanced technologies, innovative formulations, and targeted marketing to enhance product efficacy and appeal. Their strategic expansions and strong distribution networks are boosting accessibility, meeting rising consumer demand for minimally invasive aesthetic treatments, and solidifying their competitive presence in the region’s rapidly evolving beauty and wellness sector.

Recent Developments

• In May 2024, Olympus launched the ESG-410 Surgical Energy Platform, an advanced electrosurgical generator that integrates monopolar, bipolar, advanced bipolar, ultrasonic, hybrid, and PLASMA+ energy modalities, enhancing procedural efficiency across specialties such as urology, gynecology, and general surgery.

• In August 2023, Burjeel Medical City scaled up its robotic/minimally invasive program. Burjeel expanded its da Vinci/robotic surgery programme and increased the number of certified robotic surgeons across specialties (clearly relevant to gynecology capacity).

Middle East Laparoscopic Gynecological Procedures Market